BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734 AND Treatment
40868 results:

  • 1. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
    Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
    Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.
    Yang CX; Pan YX; Ye F; Zhu XD; Xue J; Li X; Yuan ZG; Zhang L; Xu L; Chen YJ; Wang NY; Sun HC; Liu XF;
    Front Immunol; 2024; 15():1310239. PubMed ID: 38711515
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Applications of Pyrrole and Pyridine-based Heterocycles in cancer Diagnosis and treatment.
    Tyagi R; Yadav K; Srivastava N; Sagar R
    Curr Pharm Des; 2024; 30(4):255-277. PubMed ID: 38711394
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. treatment strategies for borderline resectable pancreatic neuroendocrine tumors: a narrative review.
    Chang JY; Ruff SM; Cloyd JM
    Chin Clin Oncol; 2024 Apr; 13(2):25. PubMed ID: 38711178
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma with macrovascular invasion.
    Zhang Y; Zhang H; Xu H; Wang Y; Feng L; Yi F
    World J Surg Oncol; 2024 May; 22(1):122. PubMed ID: 38711095
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular interactions between metformin and D-limonene inhibit proliferation and promote apoptosis in breast and liver cancer cells.
    Salim EI; Alabasy MM; Nashar EME; Al-Zahrani NS; Alzahrani MA; Guo Z; Beltagy DM; Shahen M
    BMC Complement Med Ther; 2024 May; 24(1):185. PubMed ID: 38711049
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A case study of a liver transplant-treated patient with glycogen storage disease type Ia presenting with multiple inflammatory hepatic adenomas: an analysis of clinicopathologic and genetic data.
    Wang A; Wu J; Yuan X; Liu J; Lu C
    BMC Med Genomics; 2024 May; 17(1):124. PubMed ID: 38711024
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long-term survival after hepatic resection for colorectal liver metastases: a single-center study in Iran.
    Pourfaraji SM; Moghadam MN; Moradi AM; Shirmard FO; Mohammadzadeh N; Jafarian A
    BMC Surg; 2024 May; 24(1):131. PubMed ID: 38702645
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial).
    Lacombe K; Moh R; Chazallon C; Lemoine M; Sylla B; Fadiga F; Le Carrou J; Marcellin F; Kouanfack C; Ciaffi L; Sartre MT; Sida MB; Diallo A; Gozlan J; Seydi M; Cissé V; Danel C; Girard PM; Toni TD; Minga A; Boyer S; Carrieri P; Attia A;
    Sci Rep; 2024 May; 14(1):10244. PubMed ID: 38702350
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficacy and safety of transarterial chemoembolization combined with targeted therapy and immunotherapy versus with targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
    Feng J; Zhao Y; Zhai L; Zhou J
    Medicine (Baltimore); 2024 May; 103(18):e38037. PubMed ID: 38701263
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Self-Amplified pH/ROS Dual-Responsive Co-Delivery Nano-System with Chemo-Photodynamic Combination Therapy in Hepatic Carcinoma treatment.
    Huang Y; Wu S; Li J; He C; Cheng Y; Li N; Wang Y; Wu Y; Zhang J
    Int J Nanomedicine; 2024; 19():3737-3751. PubMed ID: 38699684
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors.
    Sun W; Yin X; Liu X; Wei J; Yu M; Li W; Ding X; Chen J
    Front Immunol; 2024; 15():1380477. PubMed ID: 38698848
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ficolin 3 promotes ferroptosis in HCC by downregulating IR/SREBP axis-mediated MUFA synthesis.
    Yuan Y; Xu J; Jiang Q; Yang C; Wang N; Liu X; Piao HL; Lu S; Zhang X; Han L; Liu Z; Cai J; Liu F; Chen S; Liu J
    J Exp Clin Cancer Res; 2024 May; 43(1):133. PubMed ID: 38698462
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Evaluation of TikTok videos on acute pancreatitis: content quality and reliability analysis.
    Mao T; Zhao X; Jiang K; Yang J; Xie Q; Fu J; Du B; Lei Z; Gao F
    BMC Public Health; 2024 May; 24(1):1216. PubMed ID: 38698404
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Predictive factors of 90-day mortality after curative hepatic resection for hepatocellular carcinoma: a western single-center observational study.
    Vaghiri S; Lehwald-Tywuschik N; Prassas D; Safi SA; Kalmuk S; Knoefel WT; Dizdar L; Alexander A
    Langenbecks Arch Surg; 2024 May; 409(1):149. PubMed ID: 38698255
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tebentafusp in the treatment of metastatic uveal melanoma - the first patient treated in the Czech Republic.
    Klabusay M; Bábková B
    Klin Onkol; 2024; 38(2):134-138. PubMed ID: 38697822
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Current State of liver Transplantation for Cholangiocarcinoma: A Comprehensive Literature Review.
    Mansoor J; Heaton N; Junaid Z
    Exp Clin Transplant; 2024 Mar; 22(3):167-179. PubMed ID: 38695585
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors.
    Liu M; Jin Q; Wang H; Li Y
    Front Immunol; 2024; 15():1396927. PubMed ID: 38690276
    [TBL] [Abstract] [Full Text] [Related]  

  • 19.
    Waziri P; Auta R; Imam MU; Chindo BA; Ladan Z; Mohammed Z; Wayah S; Mohammed J; Tahir MI; Ahmad AE; Alhassan Y; Tyoapine D; Agbaji AS
    J Evid Based Integr Med; 2024; 29():2515690X241251558. PubMed ID: 38689490
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.
    Zeng TM; Jiang TY; Yang G; Cheng Z; Lou C; Wei W; Tao CJ; Hu S; Wang H; Cui XW; Tan YX; Dong LW; Wang HY; Yuan ZG
    Clin Transl Med; 2024 May; 14(5):e1675. PubMed ID: 38689424
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2044.